InvestSMART

Starpharma Holdings Limited (ASX: SPL) - Announcements

Current share price for SPL : $0.840 0.025 (3.07%)+

ASX company news and announcements for Starpharma Holdings Limited (SPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Starpharma Holdings Limited (SPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Starpharma Holdings Limited (SPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Starpharma Holdings Limited (SPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$401 Notice of Annual General Meeting/Proxy Form 16 Oct 2015 10:25AM $0.755 $0.840 risen by 11.26%
$401 Additional US Patent Granted for VivaGel BV 14 Oct 2015 9:42AM $0.780 $0.840 risen by 7.69%
$401 Change in Director's Interest Notice - J Fairley 9 Oct 2015 3:44PM $0.745 $0.840 risen by 12.75%
$401 Appendix 3B 9 Oct 2015 3:39PM $0.750 $0.840 risen by 12%
$401 OTCQX Life Sciences Presentation 1 Oct 2015 4:53PM $0.780 $0.840 risen by 7.69%
$401 Appendix 3B 28 Sep 2015 2:35PM $0.730 $0.840 risen by 15.07%
$401 Change in Director's Interest Notice - R Thomas 28 Sep 2015 10:54AM $0.710 $0.840 risen by 18.31%
$401 EU Marketing Approval Granted for VivaGel BV 24 Sep 2015 10:09AM $0.700 $0.840 risen by 20%
$401 Date of Annual General Meeting 21 Sep 2015 5:17PM $0.710 $0.840 risen by 18.31%
$401 Change in Director's Interest Notice - R Hazleton 21 Sep 2015 10:40AM $0.705 $0.840 risen by 19.15%
$401 Change in Director's Interest Notice - P Turvey 10 Sep 2015 5:42PM $0.715 $0.840 risen by 17.48%
$401 Change in Director's Interest Notice - Z Peach 9 Sep 2015 12:40PM $0.730 $0.840 risen by 15.07%
$401 Change in Director's Interest Notice - J Fairley 9 Sep 2015 12:39PM $0.725 $0.840 risen by 15.86%
$401 Change in Director's Interest Notice - R Thomas 9 Sep 2015 12:37PM $0.725 $0.840 risen by 15.86%
$401 Drug delivery license with AstraZeneca conference call 7 Sep 2015 9:11AM $0.610 $0.840 risen by 37.70%
$401 Starpharma signs drug delivery license with AstraZeneca 7 Sep 2015 8:36AM $0.610 $0.840 risen by 37.70%
$401 Annual report and full year financial results 21 Aug 2015 12:00PM $0.635 $0.840 risen by 32.28%
$401 Appendix 4G - Corporate Governance Statement 21 Aug 2015 11:58AM $0.635 $0.840 risen by 32.28%
$401 Appendix 4C - Quarterly Cashflow Report 30 Jul 2015 9:35AM $0.670 $0.840 risen by 25.37%
$401 Change in substantial holding 30 Jun 2015 6:24PM $0.730 $0.840 risen by 15.07%
$401 Becoming a substantial holder 10 Jun 2015 8:24AM $0.730 $0.840 risen by 15.07%
$401 Change in Director's Interest Notice - J Fairley 27 May 2015 5:07PM $0.800 $0.840 risen by 5%
$401 Change in substantial holding 8 May 2015 4:47PM $0.730 $0.840 risen by 15.07%
$401 AstraZeneca to develop oncology drug using DEP technology 4 May 2015 8:41AM $0.605 $0.840 risen by 38.84%
$401 Ceasing to be a substantial holder 1 May 2015 4:16PM $0.605 $0.840 risen by 38.84%

651 - 675 of 889 results

Page 27 of 36

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.